// App-Quantinova.ai

TCT-50 : Incidence and Prognostic Significance of Heart Failure Hospitalization After Transcatheter or Surgical Aortic Valve Replacement: Results From the PARTNER Trials

Researchers

Presenter

  • Chetan Huded

Principal Investigators

  • Suzanne Arnold

  • Adnan Chhatriwalla

  • John Saxon

  • Samir Kapadia

  • Xiao Yu

  • John Webb

  • Vinod Thourani

  • Susheel Kodali

  • Michael Mack

  • Martin Leon

  • David Cohen

Medical Centers

  • Edwards Lifesciences, Irvine, California, USA

  • St Paul’s Hospital, Vancouver, British Columbia, Canada

  • Saint Luke’s Mid America Heart Institute, Kansas City, Missouri, USA

  • St. Francis Hospital, New York, New York, USA

  • Baylor Scott & White-The Heart Hospital-Plano, Plano, Texas, USA

  • Cleveland Clinic Cleveland Ohio USA

  • CIVT/Columbia University Medical Center, New York, New York, USA

  • Marcus Heart Valve Center, Piedmont Heart Institute, Atlanta, GA, USA

  • NewYork–Presbyterian/Columbia University Irving Medical Center, New York, New York, USA

Locations

  • United States

  • Canada

Companies

  • N/A

Study Components

Therapeutic Area

  • Cardiovascular (CVS)

Disease

  • Heart muscle disease

  • Congestive heart failure

Biomarkers

  • N/A

Drug/Treatment

  • N/A

Outcome

  • N/A

Study Design

  • Cohort

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Final

Copyright © 2026. QuantiNova All rights reserved